203 related articles for article (PubMed ID: 35142151)
1. A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas.
Wang X; Su W; Gao Y; Feng Y; Wang X; Chen X; Hu Y; Ma Y; Ou Q; Liang D; Huang H
Haematologica; 2022 Sep; 107(9):2154-2162. PubMed ID: 35142151
[TBL] [Abstract][Full Text] [Related]
2. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
4. The molecular hallmarks of primary and secondary vitreoretinal lymphoma.
Bonzheim I; Sander P; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Steinhilber J; Kohler E; Büssgen M; Schittenhelm J; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
Blood Adv; 2022 Mar; 6(5):1598-1607. PubMed ID: 34448823
[TBL] [Abstract][Full Text] [Related]
5. Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma.
Brown NA; Rao RC; Betz BL
J Vis Exp; 2024 Jan; (203):. PubMed ID: 38284545
[TBL] [Abstract][Full Text] [Related]
6. APRIL and BAFF play a key role in differentiating vitreoretinal lymphoma from uveitis.
Tian S; Chen K; Xiao J; Wang D; Zhou X; Li X; Shi H; Li Y; Cao X; Guan M; Chen B; Wang Q
Clin Chim Acta; 2022 Oct; 535():1-6. PubMed ID: 35820532
[TBL] [Abstract][Full Text] [Related]
7. Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy.
Balikov DA; Hu K; Liu CJ; Betz BL; Chinnaiyan AM; Devisetty LV; Venneti S; Tomlins SA; Cani AK; Rao RC
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576156
[TBL] [Abstract][Full Text] [Related]
8. Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation.
Tan WJ; Wang MM; Castagnoli PR; Tang T; Chan ASY; Lim TS
Ophthalmology; 2021 Jul; 128(7):1079-1090. PubMed ID: 33221324
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma.
Chen K; Li X; Wang D; Ma Y; Chen B; Wang Q; Ma J; Guan M
Clin Chim Acta; 2021 Apr; 515():21-26. PubMed ID: 33387464
[TBL] [Abstract][Full Text] [Related]
10. Aqueous Humor-Derived MYD88 L265P Mutation Analysis in Vitreoretinal Lymphoma: A Potential Less Invasive Method for Diagnosis and Treatment Response Assessment.
Demirci H; Rao RC; Elner VM; Demirci FY; Axenov L; Betz B; Behdad A; Brown N
Ophthalmol Retina; 2023 Feb; 7(2):189-195. PubMed ID: 35952929
[TBL] [Abstract][Full Text] [Related]
11. Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation.
Kwak JJ; Lee KS; Lee J; Kim YJ; Choi EY; Byeon SH; Chang WS; Kim YR; Kim JS; Shin S; Lee ST; Kim SS; Lee CS
Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):27. PubMed ID: 37975847
[TBL] [Abstract][Full Text] [Related]
12. USE OF A THRESHOLD OF INTERLEUKIN-10 AND IL-10/IL-6 RATIO IN OCULAR SAMPLES FOR THE SCREENING OF VITREORETINAL LYMPHOMA.
Pochat-Cotilloux C; Bienvenu J; Nguyen AM; Ohanessian R; Ghesquières H; Sève P; Garnier L; Kodjikian L
Retina; 2018 Apr; 38(4):773-781. PubMed ID: 29135797
[TBL] [Abstract][Full Text] [Related]
13. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
14. Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.
Chen X; Hu Y; Su W; Yang S; Wang X; Zhang P; Hong X; Liang C; Qian Z; Li Z; Tao Y; Huang H; Liang D
Cancer Commun (Lond); 2022 Nov; 42(11):1217-1221. PubMed ID: 35920016
[No Abstract] [Full Text] [Related]
15. Cytological diagnosis of vitreoretinal lymphomas: A case series.
Quintyn JC; Olle P; Courtade-Saidi M; Laurent C; Obéric L; Quintyn-Ranty ML
Cytopathology; 2019 Jul; 30(4):385-392. PubMed ID: 31033057
[TBL] [Abstract][Full Text] [Related]
16. [Molecular diagnostics for vitreoretinal lymphoma].
Bonzheim I; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):150-154. PubMed ID: 37947807
[TBL] [Abstract][Full Text] [Related]
17. Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.
Shi H; Zhou X; Chen B; Xiao J; Li Y; Zhou X; Zhou Q; Chen K; Wang Q
Ocul Immunol Inflamm; 2021 Apr; 29(3):448-455. PubMed ID: 31603365
[No Abstract] [Full Text] [Related]
18. Vitreous Humor Proteomic Profile in Patients With Vitreoretinal Lymphoma.
Komatsu H; Usui Y; Tsubota K; Fujii R; Yamaguchi T; Maruyama K; Wakita R; Asakage M; Hamada K; Yamakawa N; Nezu N; Ueda K; Goto H
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):2. PubMed ID: 38038618
[TBL] [Abstract][Full Text] [Related]
19. Molecular Characterization of a Rare Case of Bilateral Vitreoretinal T Cell Lymphoma through Vitreous Liquid Biopsy.
Cani AK; Toral MA; Balikov DA; Betz BL; Hu K; Liu CJ; Prifti MV; Chinnaiyan AM; Tomlins SA; Mahajan VB; Rao RC
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198843
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
Kaburaki T; Taoka K
Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]